Trials / Completed
CompletedNCT03586505
Tolerance to Light for Patients Suffering From Keratitis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In order to develop an innovative device to study infectious keratitis, we need to illuminate the cornea of patients suffering from an infectious keratitis with red or near-infrared light. Because of technical reasons the shortest possible wavelength (red) presents advantages.
Detailed description
The aim of this preliminary study is to measure the maximal intensity tolerated during illumination with 6 wavelength corresponding : 2 red, 2 far red and 1 near infrared lights in order to determine the shortest wavelength well tolerated by patients, in comparison with the standard blue light illumination.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Light exposure | The 6 lights used randomly are : * 482nm =standard blue light illumination, * 650nm, * 675nm, * 700nm, * 750nm * 800nm |
Timeline
- Start date
- 2018-07-03
- Primary completion
- 2019-08-07
- Completion
- 2019-08-07
- First posted
- 2018-07-13
- Last updated
- 2019-09-17
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03586505. Inclusion in this directory is not an endorsement.